Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y007613 | SC / LA |
Patient was given MMR vaccine while on Skyrizi and therefore immunocompromised.
Circulatory Essential hypertension (HRC) Digestive Irritable bowel syndrome Reproductive Genital herpes simplex (HRC) Respiratory Mild intermittent asthma without complication (HRC) Skin Folliculitis Psoriasis Other Hx of laparoscopic gastric banding Post-menopausal
albuterol 2.5 mg/3 mL, 0.083%, (PROVENTIL) nebulizer solution clobetasol (TEMOVATE) 0.05 % external solution clobetasol (TEMOVATE) 0.05 % ointment desonide (DESOWEN) 0.05 % ointment diclofenac (VOLTAREN) 1 % gel estrogens, conjugated (PREMA
CodeineOther, see comments Hydrocodone-acetaminophenGastrointestinal MorphineGastrointestinal
MMR Titers were completed 8/24/16 ? immune to all